An Updated Therapeutic Strategy for Chronic Idiopathic Urticaria

J Drugs Dermatol. 2021 Mar 1;20(3):354-355. doi: 10.36849/JDD.0421.
No abstract available

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Cetirizine / therapeutic use
  • Chronic Urticaria / drug therapy*
  • Chronic Urticaria / immunology
  • Chronic Urticaria / psychology
  • Dermatology / methods*
  • Dermatology / standards
  • Drug Therapy, Combination / methods
  • Drug Therapy, Combination / standards
  • Humans
  • Off-Label Use*
  • Omalizumab / therapeutic use
  • Practice Guidelines as Topic
  • Quality of Life
  • Randomized Controlled Trials as Topic
  • Tranexamic Acid / therapeutic use
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • Omalizumab
  • dupilumab
  • Tranexamic Acid
  • levocetirizine
  • Cetirizine